|
    PFE U.S.: NYSE

    Pfizer Inc.

    Watchlist
    PFEUS
    Premarket
    Last Updated: Sep 8, 2023 4:52 a.m. EDT Delayed quote

    $ 34.39

    0.11 0.32%
    Before Hours Volume: 749
    Close Chg Chg %
    $34.28 -0.09 -0.26%
    Advanced Charting
    Volume: 26.78M 65 Day Avg: 24.39M
    110% vs Avg
    34.04 Day Range 34.64
    34.04 52 Week Range 54.93

    Partner Center

    Your Watchlists

    Customize MarketWatch

    Have Watchlists? Log in to see them here or sign up to get started.

    Create Account … or Log In
    Symbol
    Company
    Price
    Chg/Chg %
    (Go to Your Watchlist)
    No Items in Watchlist

    There are currently no items in this Watchlist.

    Add Tickers
    No Saved Watchlists

    Create a list of the investments you want to track.

    Create Watchlist …or learn more
    Uh oh

    Something went wrong while loading Watchlist.

    Go to Watchlist

    Recently Viewed Tickers

    No Recent Tickers

    Visit a quote page and your recently viewed tickers will be displayed here.

    Overview

  • Overview
  • Profile
  • Charts
  • Financials
  • Historical Quotes
  • Analyst Estimates
  • Options
  • Premium Tools

    • PFE Overview

    Key Data

    • Open $34.47
    • Day Range 34.04 - 34.64
    • 52 Week Range 34.04 - 54.93
    • Market Cap $194.05B
    • Shares Outstanding 5.65B
    • Public Float 5.64B
    • Beta 0.59
    • Rev. per Employee $939.08K
    • P/E Ratio 9.13
    • EPS $3.75
    • Yield 4.78%
    • Dividend $0.41
    • Ex-Dividend Date Jul 27, 2023
    • Short Interest 52.39M 08/15/23
    • % of Float Shorted 0.93%
    • Average Volume 24.39M

    Performance

    5 Day
    • -4.19%
    1 Month
    • -4.88%
    3 Month
    • -12.03%
    YTD
    • -33.10%
    1 Year
    • -28.34%

    Analyst Ratings

    • Sell
    • Under
    • Hold
    • Over
    • Buy
    Number of Ratings 27 Full Ratings

    Recent News

    Read full story

    Pfizer Inc. stock underperforms Thursday when compared to competitors

    Sep. 7, 2023 at 4:36 p.m. ET by MarketWatch Automation
    Read full story

    Pfizer Inc. stock underperforms Wednesday when compared to competitors

    Sep. 6, 2023 at 4:36 p.m. ET by MarketWatch Automation

    Moderna says updated COVID vaccine effective against BA.2.86 Pirola variant

    Sep. 6, 2023 at 8:12 a.m. ET by Eleanor Laise
    Read full story

    Pfizer Inc. stock underperforms Tuesday when compared to competitors

    Sep. 5, 2023 at 4:36 p.m. ET by MarketWatch Automation
    Read full story

    Coronavirus New Covid-19 Variant Might Not Be That Bad. More Boosters Are Coming Soon.

    Sep. 5, 2023 at 4:30 p.m. ET by Barron's
    Read full story

    Pfizer Inc. stock outperforms market on strong trading day

    Sep. 1, 2023 at 4:36 p.m. ET by MarketWatch Automation

    Pfizer, BioNTech Get CHMP Backing for Omicron XBB.1.5-Adapted Covid-19 Vaccine

    Aug. 30, 2023 at 10:36 a.m. ET

    Pfizer, BioNTech updated COVID vaccine to treat new variants gets CHMP recommendation use in Europe

    Aug. 30, 2023 at 10:15 a.m. ET by Tomi Kilgore

    Pfizer Expects to Resume Drug Manufacturing At N.C. Plant In 4Q

    Aug. 28, 2023 at 2:45 p.m. ET
    Read full story

    Biotech and Pharma Biden Administration to Reveal Which Pharma Blockbusters Medicare Will Pay Less For

    Aug. 28, 2023 at 3:00 a.m. ET by Barron's
    Read full story

    Bullish on Nvidia? This single-stock ETF could offer 1.5 times leverage on the popular chip stock — but be careful what you wish for.

    Aug. 26, 2023 at 8:42 a.m. ET by Isabel Wang
    Read full story

    Markets The Nvidia Distraction Is Over. Jackson Hole, Powell, Bonds Take Center Stage.

    Aug. 25, 2023 at 6:45 a.m. ET
    Read full story

    Biotech and Pharma Covid-19 Hospitalizations Jump. So Could Vaccine Demand.

    Aug. 22, 2023 at 4:46 p.m. ET by Barron's

    Novavax says updated COVID vaccine effective against Eris, other new variants

    Aug. 22, 2023 at 7:57 a.m. ET by Eleanor Laise
    Read full story

    Pfizer maternal RSV vaccine gets FDA approval

    Aug. 22, 2023 at 7:54 a.m. ET by Eleanor Laise

    Pfizer Gets FDA OK for Maternal Use of Abrysvo RSV Vaccine >PFE

    Aug. 21, 2023 at 5:32 p.m. ET
    Read full story

    As COVID hospitalizations rise, Pfizer and Moderna say updated shots show promise against Eris variant

    Aug. 19, 2023 at 2:53 p.m. ET by Eleanor Laise
    Read full story

    Biotech and Pharma Buy Moderna and BioNTech Stock. Both Pharmas Have Strong Drug Pipelines and Plenty of Cash.

    Aug. 18, 2023 at 5:02 p.m. ET by Barron's
    Read full story

    Biotech and Pharma 6 Pharma and Life Sciences Stocks That Are Actually Up This Year

    Aug. 16, 2023 at 12:30 a.m. ET by Barron's

    Pfizer gets FDA accelerated approval for multiple myeloma treatment

    Aug. 14, 2023 at 2:40 p.m. ET by Eleanor Laise

    Stocks That Hit 52-Week Lows On Thursday

    Sep. 7, 2023 at 1:55 p.m. ET on Benzinga.com

    Moderna (MRNA) Updated COVID Jab Effective Against Pirola Variant

    Sep. 7, 2023 at 11:20 a.m. ET on Zacks.com

    Could Pfizer Stock Help You Become A Millionaire?

    Sep. 7, 2023 at 9:15 a.m. ET on Motley Fool

    3 Dividend Stocks That Could Be Ideal Buys for Retirees in September

    Sep. 7, 2023 at 7:53 a.m. ET on Motley Fool

    Pfizer, Valneva's Tick-Borne Infection Shot: Companies Say 'Positive' Result For Lyme Disease Vaccine Candidate Booster

    Sep. 7, 2023 at 7:32 a.m. ET on Benzinga.com

    Pfizer Stock (NYSE:PFE) Hits a New Low; What’s Ahead?

    Sep. 7, 2023 at 3:10 a.m. ET on TipRanks.com

    GameStop, Apple, Pfizer, Tesla, AMC: Why These 5 Stocks Are Trending Today

    Sep. 6, 2023 at 9:45 p.m. ET on Benzinga.com

    How To Earn $500 From Pfizer Stock With Shares Trading At 52-Week Low

    Sep. 6, 2023 at 6:37 p.m. ET on Benzinga.com

    Non-Disappearing COVID Creates Another Chapter For The Pharmaceutical Industry

    Sep. 6, 2023 at 4:39 p.m. ET on Benzinga.com

    Stocks on the Mend: A Mean Reversion Duo

    Sep. 6, 2023 at 1:16 p.m. ET on Zacks.com

    Cantor Fitzgerald Remains a Buy on Pfizer (PFE)

    Sep. 5, 2023 at 8:26 p.m. ET on TipRanks.com

    3 Forever Stocks to Buy With $100

    Sep. 5, 2023 at 2:00 p.m. ET on Motley Fool

    Novo Nordisk (NVO) Launches Wegovy in UK Amid Supply Issues

    Sep. 5, 2023 at 1:52 p.m. ET on Zacks.com

    10 Health Care Stocks With Whale Alerts In Today's Session

    Sep. 5, 2023 at 1:35 p.m. ET on Benzinga.com

    Pyxis Oncology M&A Spotlight Signals Potential Growth Amidst Competitive ADC Landscape: Analyst

    Sep. 5, 2023 at 12:43 p.m. ET on Benzinga.com

    Novavax (NVAX) Stock Increases 9% in a Month: Here's Why

    Sep. 5, 2023 at 12:10 p.m. ET on Zacks.com

    Cancer Remains Pharma's Biggest Challenge And Mainz Biomed Has The Tool To Help Win The Battle

    Sep. 5, 2023 at 12:06 p.m. ET on Benzinga.com

    Pfizer Unusual Options Activity

    Sep. 5, 2023 at 12:00 p.m. ET on Benzinga.com

    Coronavirus Cases Are on the Rise -- Should You Buy Vaccine Stocks?

    Sep. 5, 2023 at 5:30 a.m. ET on Motley Fool

    The 3 Best Biotech Stocks to Buy Now: September 2023

    Sep. 4, 2023 at 3:43 p.m. ET on InvestorPlace.com

    Pfizer Inc.

    Pfizer Inc. is a research-based global biopharmaceutical company. It engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

    Competitors

    Name Chg % Market Cap
    Johnson & Johnson 1.28% $380.49B
    Eli Lilly & Co. 2.37% $531.56B
    Abbott Laboratories -0.88% $176.24B
    Merck & Co. Inc. 1.36% $270.22B
    Novartis AG 1.63% CHF173.84B
    AstraZeneca PLC ADR -1.72% $205.31B
    AstraZeneca PLC 2.06% £164.38B
    Bristol Myers Squibb Co. 0.50% $124.66B
    Amgen Inc. 2.16% $133.2B
    Moderna Inc. 0.10% $41.2B